4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia (Q43583147)

24 November 2017

title

4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia (English)

1 reference

24 November 2017

10

1 reference

24 November 2017

Gotho Geishofer

1

1 reference

24 November 2017

Alexander Binder

2

1 reference

24 November 2017

Martin Müller

3

1 reference

24 November 2017

Bettina Zöhrer

4

1 reference

24 November 2017

Bernhard Resch

5

1 reference

24 November 2017

Wilhelm Müller

6

1 reference

24 November 2017

Jörg Faber

7

1 reference

24 November 2017

Adam Finn

8

1 reference

24 November 2017

Georg Endler

9

1 reference

24 November 2017

Werner Zenz

11

1 reference

24 November 2017

Central European Meningococcal Genetic Study Group

12

1 reference

24 November 2017

language of work or name

1 reference

21 April 2005

1 reference

European Journal of Pediatrics

24 November 2017

published in

1 reference

24 November 2017

volume

164

1 reference

24 November 2017

issue

8

1 reference

24 November 2017

page(s)

486-490

1 reference

Complex regulation of plasminogen activator inhibitor type-1 (PAI-1) gene expression by serum and substrate adhesion

24 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007/S00431-005-1673-4

Skin manifestations of meningococcal infection; an immediate indicator of prognosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007/S00431-005-1673-4

Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease

21 January 2018

1 reference

12 December 2020

Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family

1 reference

12 December 2020

Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response

1 reference

12 December 2020

Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis

1 reference

12 December 2020

4G/5G promoter PAI-1 gene polymorphism is associated with plasmatic PAI-1 activity in Italians: a model of gene-environment interaction

1 reference

12 December 2020

Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcemia

1 reference

12 December 2020

4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease

1 reference

12 December 2020

Risks and benefits of activated protein C treatment for severe sepsis

1 reference

12 December 2020

Deficiency of prostacyclin production in meningococcal shock

1 reference

12 December 2020

Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes.

1 reference

12 December 2020

Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor

1 reference

12 December 2020

The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells.

1 reference

12 December 2020

Treatment of fulminant meningococcemia with recombinant tissue plasminogen activator

1 reference

12 December 2020

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

12 December 2020

Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor

1 reference

12 December 2020

Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro

1 reference

12 December 2020

Sepsis syndrome and septic shock in pediatrics: current concepts of terminology, pathophysiology, and management.

1 reference

12 December 2020

The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock

1 reference

12 December 2020

Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects

1 reference

12 December 2020

Meningococcemia and purpura fulminans in adults: acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates

1 reference

12 December 2020

Purpura fulminans in meningococcemia: association with acquired deficiencies of proteins C and S.

1 reference

12 December 2020

Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: A retrospective study*

1 reference

12 December 2020

Plasminogen Activator Inhibitor-1 (PAI-1) Antigen Plasma Levels in Subjects Attending a Metabolic Ward: Relation to Polymorphisms of PAI-1 and Angiontensin Converting Enzyme (ACE) Genes

1 reference

12 December 2020

Complement activation and endotoxin levels in systemic meningococcal disease

1 reference

12 December 2020

Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock

1 reference

12 December 2020

Extreme plasminogen activator inhibitor and endotoxin values in patients with meningococcal disease

1 reference

12 December 2020

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction

1 reference

12 December 2020

The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease

1 reference

12 December 2020

Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children*

1 reference

12 December 2020

10.1007/S00431-005-1673-4

Identifiers

DOI

1 reference

24 November 2017

1 reference